GlassScriptPhysician profile
Mark S Hayes
NPI 1730359522
$1,803.90
in general payments reported to CMS, 2019-2025
19 companies · $489 in 2025
The $489 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $71.99 · 2021: $123 · 2022: $70.28 · 2023: $254 · 2024: $537 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146 · Entertainment: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.98 |
| Entertainment | $133.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $398.69 | 2019-2025 | Clareon, Eysuvis, Wavelight Refractive Suite |
| Johnson & Johnson Surgical Vision, INC. | $288.23 | 2019-2025 | Tecnis Simplicity, Veritas Vision System, Tecnis Iol |
| Biotissue Holdings INC. | $209.29 | 2021-2025 | |
| Abbvie INC. | $145.90 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $138.55 | 2023-2025 | Miebo, Vyzulta, Scoutpro Osmolarity System |
| Optos, INC. | $133.82 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sight Sciences, INC. | $75.42 | 2025 | Omni Surgical System |
| Rxsight INC | $74.78 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Rayner Intraocular Lenses Limited | $65.54 | 2023-2025 | Rayone Emv, Rayone Aspheric, Rayone Spheric |
| Sun Pharmaceutical Industries INC. | $49.83 | 2021-2023 | Cequa |
| Ocular Therapeutix, INC. | $44.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.01 | 2023 | |
| Lombart Brothers, INC. | $23.27 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $21.86 | 2024 | Xdemvy |
| Thea Pharma INC. | $20.23 | 2023 | Iyuzeh |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.02 | 2021 | |
| Lensar, INC. | $18.93 | 2024 | Lensar Laser System |
| Eyevance Pharmaceuticals LLC | $18.03 | 2022 | |
| Harrow Eye, LLC | $17.09 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.